Arrowhead Research
ARWR
67 hedge funds and large institutions have $262M invested in Arrowhead Research in 2013 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
1,100% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 3
277% more capital invested
Capital invested by funds: $69.4M → $262M (+$192M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
97% more funds holding
Funds holding: 34 → 67 (+33)
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
36% more call options, than puts
Call options by funds: $1.88M | Put options by funds: $1.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$17M |
| 2 |
QF
QVT Financial
New York
|
+$16.4M |
| 3 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
+$12M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.5M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$7.99M |
| 2 |
PC
PointState Capital
New York
|
-$3.2M |
| 3 |
SC
Sophrosyne Capital
New York
|
-$1.23M |
| 4 |
Goldman Sachs
New York
|
-$811K |
| 5 |
SIM
SSI Investment Management
Los Angeles,
California
|
-$405K |
ARWR Hedge Fund Activity: Q4 2013 in Review
67 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Arrowhead Research (ARWR) for Q4 2013, worth a combined $262M — up 277% from $69.4M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new ARWR positions and 3 closed out — a net gain of 33 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $17M. The largest seller was Camber Capital Management, cutting an estimated $7.99M.
- 67 institutional investors held Arrowhead Research (ARWR) as of Q4 2013, up from 34 in Q3 2013.
- Funds reported $262M of Arrowhead Research stock for Q4 2013, up 277% quarter-over-quarter.
- 36 funds opened new Arrowhead Research positions in Q4 2013 and 3 closed out, a net change of +33 holders.
- The largest Arrowhead Research buyer in Q4 2013 was OrbiMed, an estimated $17M added.
- The largest Arrowhead Research seller in Q4 2013 was Camber Capital Management, an estimated $7.99M sold.
Based on aggregated 13F filings for Q4 2013.